SFM Fetal Therapy Practice Guidelines: Fetal Cystoscopic Laser Ablation
Journal of Fetal Medicine · 01.12.2023 · 10 (04) · 175-181
DOI: 10.1055/s-0044-1782222 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Fetal Medicine, erschienen am 01.12.2023. Verfasst von Gourisankar Rudrapal und 2 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Fetal lower urinary tract obstruction (LUTO) in a male fetus could cause detrimental effects to the KUB (kidney, ureter, and bladder) system from back-pressure changes as well as to the lungs from reduced amniotic fluid. In a carefully selected case where the obstruction causes progressive damage, a therapeutic intervention could be lifesaving. In utero vesico-amniotic shunting has been shown to improve perinatal pulmonary survival, but evidence on improvement of renal outcomes with this procedure is lacking. More recently, fetal cystoscopic laser fulguration has been shown to be beneficial in longer-term survival and renal outcomes. These interventions carry significant risk, and therefore patient selection and optimal timing are key. This guideline lists the intricacies of patient selection, relevant counseling points and procedural details.
Zitieren
APA
Rudrapal, G., Makkam, A., & Krishnan, V. (2023). SFM Fetal Therapy Practice Guidelines: Fetal Cystoscopic Laser Ablation. Journal of Fetal Medicine, 10(04), 175-181. https://doi.org/10.1055/s-0044-1782222
Vancouver
Rudrapal G, Makkam A, Krishnan V. SFM Fetal Therapy Practice Guidelines: Fetal Cystoscopic Laser Ablation. Journal of Fetal Medicine. 2023;10(04):175-181. doi:10.1055/s-0044-1782222
BibTeX
@article{Rudrapal2023,
author = {Rudrapal, Gourisankar and Makkam, Adinarayan and Krishnan, Vivek},
title = {SFM Fetal Therapy Practice Guidelines: Fetal Cystoscopic Laser Ablation},
journal = {Journal of Fetal Medicine},
year = {2023},
volume = {10},
number = {04},
pages = {175--181},
doi = {10.1055/s-0044-1782222}
}
EUVIMED